New coding guidance: MUEs added for compound drugs, revised CCI edits for joint injections

Why This Topic Matters

Quarterly edit changes can alter claim editing behavior, denial patterns, and appeal needs for common outpatient services. The article helps readers understand which service categories are being affected so they can review workflows and compliance practices.

Article Sections

1. Limits for compounded drugs

   Summarizes the update category involving medically unlikely edits for compounded drugs and the general impact on billing review. It also notes the relevance of appeal handling for higher-unit claims.

2. A sprinkling of CCI edits will impact pain providers

   Introduces the main CCI-related service categories discussed in the update and frames the changes as especially relevant to pain and procedural practices.

3. Arthrocentesis

   Covers edit changes affecting joint aspiration and injection services in relation to other same-day procedures and modifier use in distinct-service situations.

4. Transforaminal epidural injections

   Describes edit changes involving transforaminal epidural injection coding in relation to other spine and joint procedures and the associated reporting context.

5. Prolonged services

   Reviews edit changes involving prolonged service codes and substance abuse screening service categories, including the payment and bundling context discussed in the update.

6. CCI version 24.1, MUE scorecard

   Presents the summary scorecard for the quarterly update, showing the volume of coding edits by broad code range and overall effective date context.